Carotid baroreflex activation therapy for resistant hypertension

Area of Science:

• Cardiovascular physiology
• Biomedical engineering
• Hypertension management

Background:

• Arterial baroreceptors regulate blood pressure.
• Carotid baroreflex activation therapy (CAT) is a device-based intervention for resistant hypertension.
• Previous trials faced challenges with efficacy and safety (facial nerve injury).

Purpose of the Study:

• To evaluate the efficacy and safety of a novel, miniaturized carotid baroreceptor pacemaker for resistant hypertension.
• To assess the potential of unilateral carotid sinus stimulation.
• To address limitations of earlier device generations.

Main Methods:

• Utilizing a miniaturized second-generation pacing electrode for carotid sinus stimulation.
• Conducting a phase III clinical trial for resistant hypertension.
• Employing unilateral carotid sinus stimulation to overcome counteracting reflexes.

Main Results:

• Early results suggest efficacy of unilateral carotid sinus stimulation.
• The miniaturized electrode appears to have overcome previous safety concerns regarding facial nerve injury.
• A new phase III trial has been registered to further evaluate the device.

Conclusions:

• The second-generation carotid baroreceptor pacemaker shows promise for treating resistant hypertension.
• This device-based therapy may offer a supplementary treatment option for patients.
• Further clinical trials are necessary to confirm long-term efficacy and safety.